|
covid-19 |
50 |
|
sars-cov-2 |
50 |
|
coronavirus |
25 |
|
interferon |
25 |
|
mouse |
22 |
|
animals |
20 |
|
humans |
20 |
|
phylogeny |
20 |
|
adult |
18 |
|
animal |
18 |
|
h1n1 |
16 |
|
influenza |
16 |
|
omicron |
16 |
|
receptor binding domain |
16 |
|
hemagglutinin |
15 |
|
influenza, human - epidemiology - virology |
15 |
|
molecular sequence data |
15 |
|
zika |
15 |
|
disease outbreaks |
14 |
|
flavivirus |
14 |
|
human |
14 |
|
immune activation |
14 |
|
intestine |
14 |
|
polymerase chain reaction |
14 |
|
replication |
14 |
|
sars-cov |
14 |
|
antigens, viral - analysis |
13 |
|
china - epidemiology |
13 |
|
pandemic |
13 |
|
sequence analysis, dna |
13 |
|
treatment |
13 |
|
base sequence |
12 |
|
cats |
12 |
|
hemagglutination inhibition tests |
12 |
|
immunohistochemistry |
12 |
|
serotyping |
12 |
|
transmission |
12 |
|
vaccine |
12 |
|
animal cell |
11 |
|
animal tissue |
11 |
|
bat |
11 |
|
coronavirus disease 2019 |
11 |
|
feces analysis |
11 |
|
hamster |
11 |
|
molecular epidemiology |
11 |
|
murine |
11 |
|
n501y |
11 |
|
rat |
11 |
|
sars-cov-2 variants |
11 |
|
susceptibility |
11 |
|
acute hepatitis |
10 |
|
adaptation |
10 |
|
bronchiectasis |
10 |
|
case report |
10 |
|
chronic obstructive lung disease |
10 |
|
d222g |
10 |
|
d225g |
10 |
|
genes, viral |
10 |
|
genetic variation |
10 |
|
genotype |
10 |
|
hemagglutinin glycoproteins, influenza virus - genetics - metabolism |
10 |
|
human neutralizing antibody |
10 |
|
influenza a |
10 |
|
influenza a virus, h1n1 subtype - genetics - pathogenicity |
10 |
|
influenza a virus, h5n1 subtype - classification - genetics - isolation & purification |
10 |
|
influenza in birds - epidemiology - virology |
10 |
|
lung injury |
10 |
|
mutation - genetics |
10 |
|
nasal turbinate |
10 |
|
phage display |
10 |
|
poultry - virology |
10 |
|
prevalence |
10 |
|
rna, viral - genetics |
10 |
|
sialic acid |
10 |
|
upper respiratory tract |
10 |
|
viral proteins - genetics |
10 |
|
virus evolution |
10 |
|
aged |
9 |
|
aged mice |
9 |
|
anosmia |
9 |
|
antibodies, viral - biosynthesis |
9 |
|
astroviridae infections - epidemiology - veterinary - virology |
9 |
|
blotting, western |
9 |
|
cell surface |
9 |
|
china |
9 |
|
chiroptera - classification - virology |
9 |
|
entry |
9 |
|
evolution, molecular |
9 |
|
ex vivo |
9 |
|
h7n9 |
9 |
|
human primary nasal epithelial cells |
9 |
|
influenza a virus, h1n1 subtype - genetics - isolation and purification - physiology |
9 |
|
influenza virus |
9 |
|
internalization |
9 |
|
mamastrovirus - classification - genetics - isolation & purification |
9 |
|
model |
9 |
|
molecular sequence numbers |
9 |
|
mutation |
9 |
|
nucleolin |
9 |
|
olfactory dysfunction |
9 |
|
orchitis |
9 |
|
orthomyxoviridae infections - immunology - mortality - physiopathology - virology |
9 |
|
post-ba.2/5 subvariants |
9 |
|
smell impairment |
9 |
|
species specificity |
9 |
|
steroid |
9 |
|
t-lymphocytes - immunology |
9 |
|
temperature |
9 |
|
testis |
9 |
|
vopba |
9 |
|
weanling mice |
9 |
|
a(h1n1)pdm09 |
8 |
|
a(h3n2) |
8 |
|
adolescent |
8 |
|
age factors |
8 |
|
aged, 80 and over |
8 |
|
antibody formation |
8 |
|
asia, southeastern |
8 |
|
avian |
8 |
|
avian influenza virus |
8 |
|
chemokine |
8 |
|
chicken |
8 |
|
child |
8 |
|
child, preschool |
8 |
|
clarithromycin |
8 |
|
cytokine |
8 |
|
disease outbreaks - prevention & control |
8 |
|
ducks - virology |
8 |
|
female |
8 |
|
genetics |
8 |
|
hong kong - epidemiology |
8 |
|
hospitalized |
8 |
|
il-8 |
8 |
|
imiquimod |
8 |
|
incidence |
8 |
|
infant |
8 |
|
influenza a virus, h1n1 subtype - immunology |
8 |
|
influenza a virus, h1n1 subtype - isolation & purification - pathogenicity |
8 |
|
influenza a virus, h5n1 subtype - isolation & purification - pathogenicity |
8 |
|
influenza in birds - epidemiology - transmission - virology |
8 |
|
influenza vaccines - immunology |
8 |
|
influenza, human - epidemiology - pathology - virology |
8 |
|
influenza, human - epidemiology - prevention & control - transmission - virology |
8 |
|
influenza, human - immunology |
8 |
|
interferon lambda 1 |
8 |
|
male |
8 |
|
mask |
8 |
|
middle aged |
8 |
|
naproxen |
8 |
|
obesity |
8 |
|
oseltamivir |
8 |
|
positive selection |
8 |
|
sequence homology, amino acid |
8 |
|
severity of illness index |
8 |
|
spike mutant |
8 |
|
spike s1/s2 mutant |
8 |
|
viral load |
8 |
|
young adult |
8 |
|
adiponectin |
7 |
|
adjuvant |
7 |
|
antiviral |
7 |
|
avian influenza |
7 |
|
avian influenza a/h7n9 virus |
7 |
|
bayes theorem |
7 |
|
birds - virology |
7 |
|
bromocriptine |
7 |
|
cardiac infection |
7 |
|
cardiomyocytes |
7 |
|
chiroptera - virology |
7 |
|
cluster analysis |
7 |
|
coinfection |
7 |
|
combination therapy |
7 |
|
coronavirus - classification - enzymology - genetics - isolation & purification |
7 |
|
coronavirus - classification - genetics - isolation & purification |
7 |
|
corticosteroid |
7 |
|
defective interfering viral genome |
7 |
|
dendritic cells |
7 |
|
diagnostics |
7 |
|
disease outbreaks - history |
7 |
|
disease outbreaks - statistics & numerical data |
7 |
|
felidae - virology |
7 |
|
genome, viral |
7 |
|
h5n1 |
7 |
|
heart |
7 |
|
history, 20th century |
7 |
|
history, 21st century |
7 |
|
illumina sequencing |
7 |
|
influenza a virus - classification - genetics - isolation & purification |
7 |
|
influenza a virus - genetics |
7 |
|
influenza a virus, h5n1 subtype - classification - genetics - isolation & purification - pathogenicity |
7 |
|
influenza vaccine |
7 |
|
influenza, human - epidemiology - history |
7 |
|
leptin |
7 |
|
macrophages |
7 |
|
mdms |
7 |
|
medical sciences |
7 |
|
mice |
7 |
|
miltefosine |
7 |
|
modcs |
7 |
|
models, genetic |
7 |
|
molecular clock |
7 |
|
monoinfection |
7 |
|
mustelidae - virology |
7 |
|
olfactory neuron |
7 |
|
pathogenesis |
7 |
|
protease |
7 |
|
reassortant |
7 |
|
reassortant viruses - classification - genetics - isolation & purification |
7 |
|
remdesivir |
7 |
|
rna helicases - genetics |
7 |
|
rna replicase - genetics |
7 |
|
sequence homology |
7 |
|
severe |
7 |
|
severe acute respiratory syndrome - epidemiology - history - virology |
7 |
|
single molecule real time sequencing |
7 |
|
swine |
7 |
|
tfh |
7 |
|
untranslated |
7 |
|
virus |
7 |
|
adenovirus |
6 |
|
amantadine-pharmacology |
6 |
|
animals, domestic |
6 |
|
antigenic variation |
6 |
|
antigens, viral - genetics |
6 |
|
apoptosis |
6 |
|
biodiversity |
6 |
|
brain |
6 |
|
cattle |
6 |
|
cell line |
6 |
|
coronaviridae - classification - genetics - isolation & purification - physiology |
6 |
|
coronaviridae infections - transmission - veterinary - virology |
6 |
|
disease reservoirs - virology |
6 |
|
drug-resistance,-viral-genetics |
6 |
|
ecosystem |
6 |
|
elderly |
6 |
|
envelope |
6 |
|
genes, viral - genetics |
6 |
|
hemagglutinin glycoproteins, influenza virus - genetics |
6 |
|
hemagglutinin glycoproteins, influenza virus - genetics - immunology |
6 |
|
hepatitis e |
6 |
|
hev-c1 |
6 |
|
immunogenicity |
6 |
|
influenza a virus, h5n1 subtype - genetics - immunology - isolation & purification - pathogenicity |
6 |
|
influenza a virus, h9n2 subtype - chemistry - classification |
6 |
|
influenza in birds - virology |
6 |
|
influenza-a-virus,-h5n1-subtype-drug-effects |
6 |
|
influenza-a-virus,-h5n1-subtype-genetics |
6 |
|
intradermal |
6 |
|
live-attenuated influenza-based vaccine |
6 |
|
microscopy, electron |
6 |
|
molecular modelling |
6 |
|
morbillivirus - pathogenicity |
6 |
|
mortality |
6 |
|
mucosal immunity |
6 |
|
nasal prevention |
6 |
|
nephritis, interstitial - virology |
6 |
|
neuraminidase - genetics |
6 |
|
newly-weaned hamster |
6 |
|
novobiocin |
6 |
|
pd1-based dna vaccine |
6 |
|
poultry |
6 |
|
poultry diseases - epidemiology - virology |
6 |
|
premembrane |
6 |
|
rat hepatitis e |
6 |
|
rectum - virology |
6 |
|
respiratory |
6 |
|
rhinovirus |
6 |
|
rimantadine-pharmacology |
6 |
|
selection, genetic |
6 |
|
time factors |
6 |
|
tract |
6 |
|
viral hepatitis |
6 |
|
viverridae - virology |
6 |
|
zoonosis |
6 |
|
amino acid motifs |
5 |
|
amino acid sequence |
5 |
|
antibody titer |
5 |
|
arthralgia |
5 |
|
bird diseases - epidemiology - virology |
5 |
|
communicable diseases, emerging - epidemiology - immunology |
5 |
|
drug dosage form comparison |
5 |
|
drug dose comparison |
5 |
|
ex vivo human lung tissues |
5 |
|
ido1 |
5 |
|
indoleamine 2,3-dioxygenase |
5 |
|
influenza a virus, h1n1 subtype - classification - immunology |
5 |
|
influenza a virus, h5n1 subtype - genetics |
5 |
|
influenza a virus, h9n2 subtype - classification - genetics - isolation & purification |
5 |
|
influenza, human - epidemiology - immunology |
5 |
|
population susceptibility |
5 |
|
quail - virology |
5 |
|
respiratory tract infections |
5 |
|
serology |
5 |
|
type-ii ifn |
5 |
|
astrocytes - virology |
4 |
|
avian influenza a virus |
4 |
|
b cell |
4 |
|
cell death |
4 |
|
cytokines |
4 |
|
down-regulation |
4 |
|
h5n1 subtype |
4 |
|
human infection |
4 |
|
immune impairment |
4 |
|
inactivated influenza |
4 |
|
influenza a virus, h5n1 subtype - genetics - physiology |
4 |
|
influenza a virus, h5n1 subtype - isolation and purification |
4 |
|
influenza, human - metabolism - virology |
4 |
|
influenza, human - pathology - physiopathology - virology |
4 |
|
monocytes |
4 |
|
nuclear factor 90 proteins - chemistry - genetics - metabolism |
4 |
|
nucleoproteins - genetics - metabolism |
4 |
|
paracetamol |
4 |
|
pge2 |
4 |
|
tissue tropism |
4 |
|
antibodies, monoclonal |
3 |
|
carcinoma, squamous cell - pathology - virology |
3 |
|
cell differentiation |
3 |
|
ebv expression |
3 |
|
herpesvirus 4, human - genetics - immunology - physiology |
3 |
|
in situ hybridization |
3 |
|
influenza a virus |
3 |
|
nasopharyngeal neoplasms - pathology - virology |
3 |
|
npc differentiation |
3 |
|
saα2,3gal linkage |
3 |
|
saα2,6gal linkage |
3 |
|
sialic acid receptors |
3 |
|
viral matrix proteins - analysis |
3 |
|
virus latency |
3 |
|
virus replication |
3 |
|
actinomycin d |
2 |
|
antimetabolites, antineoplastic - pharmacology |
2 |
|
apoptosis - drug effects - physiology |
2 |
|
chromatin |
2 |
|
dactinomycin - pharmacology |
2 |
|
dna fragmentation - drug effects |
2 |
|
down-regulation - drug effects |
2 |
|
flow cytometry |
2 |
|
hl-60 cells |
2 |
|
inflammation |
2 |
|
k562 cells |
2 |
|
leukemia - enzymology - pathology |
2 |
|
puromycin |
2 |
|
puromycin - pharmacology |
2 |
|
reverse transcriptase polymerase chain reaction |
2 |
|
telomerase |
2 |
|
telomerase - metabolism |
2 |
|
topoisomerase |
2 |
|
u937 cells |
2 |
